p creb ser133 87g3 (Cell Signaling Technology Inc)
Structured Review

P Creb Ser133 87g3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 2198 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p creb ser133 87g3/product/Cell Signaling Technology Inc
Average 98 stars, based on 2198 article reviews
Images
1) Product Images from "Transcriptomic analysis identifies enrichment of cAMP/PKA/CREB signaling in invasive lobular breast cancer."
Article Title: Transcriptomic analysis identifies enrichment of cAMP/PKA/CREB signaling in invasive lobular breast cancer.
Journal: Breast cancer research : BCR
doi: 10.1186/s13058-024-01900-y
Figure Legend Snippet: Fig. 5 A Dose response curves representing growth inhibition in ILC (red: SUM44PE, MM134, MM330, WCRC25, MM453, HCC2185) and NST (blue: MCF7, T47D, MM415, BT474) cell lines in response to treatment with forskolin: Y axis represents fold change in growth after 7 days of treatment with forskolin and X axis represents log of dose of forskolin in µM B Overlapping box and jitter plot depicting IC50 (half maximal inhibitory concentration) for forskolin in ILC (red: SUM44PE, MM134, MM330, WCRC25, MM453, HCC2185) and NST (blue: MCF7, T47D, MM415, BT474) cell lines; C ILC—Invasive lobular breast cancer; NST—Invasive carcinoma—no special type; PKACA—Protein kinase A catalytic α subunit; CREB—cAMP Response Element Binding protein; p-CREB—phospho CREB, phosphorylated at Ser133; Ecad KO—E-cadherin Knock Out; IC50—Half maximal inhibitory concentration
Techniques Used: Inhibition, Concentration Assay, Binding Assay, Knock-Out
